5-(Pyridazin-3-yl)nicotinamide

Catalog No.: 
ACOOZQ213
CAS No.: 
1346687-40-8
Molecular Formula: 
C10H8N4O
Molecular Weight: 
200.20
5-(Pyridazin-3-yl)nicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$144.00InquiryInquiry
1g95%$458.00InquiryInquiry
5g95%$2244.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Pyridazin-3-yl)nicotinamide
IUPAC Name5-(pyridazin-3-yl)nicotinamide
MDL No.MFCD19689038
Molecular FormulaC10H8N4O
Molecular Weight200.20
SMILESO=C(N)C1=CN=CC(C2=NN=CC=C2)=C1
InChI KeyTZLYPVZQNRLGCC-UHFFFAOYSA-N
Synonym5-(Pyridazin-3-yl)nicotinaMide
CAS No.1346687-40-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOOZQ213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEFTD879 route compound structure diagram
    ACEFTD87988491-61-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOOZQ213 route product structure diagram
    ACOOZQ2131346687-40-8
Inquiry

2. ACOOZQ213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHLXN517 route compound structure diagram
    ACHLXN5171169402-51-0In Stock
  2. Plus
  3. ACNMJX619 route compound structure diagram
    ACNMJX6191120-95-2In Stock
  4. Then
  5. ACOOZQ213 route product structure diagram
    ACOOZQ2131346687-40-8
Inquiry

3. ACOOZQ213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNMJX619 route compound structure diagram
    ACNMJX6191120-95-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOOZQ213 route product structure diagram
    ACOOZQ2131346687-40-8
Inquiry

Comments (0)